Protagonist Therapeutics – PTGX: Einstieg von Johnson & Johnson könnte für Mega-Bounce sorgen!
Springt die Aktie auf 100 USD? Übernahmegerüchte heizen Kursentwicklung bei Protagonist Therapeutics (PTGX) an: + 67 Prozent in 6 Monaten! ...
Saturday, September 12, 2026
Tag: Therapeutics
IPO News: MapLight Therapeutics targets 704 mln valuation in Nasdaq debut
In recent months, Wall Street has seen a surge of healthcare firms seeking to go public, as IPO activity continues ...
What Does Wall Street Think About Beam Therapeutics (BEAM)?
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the best biotech stocks with high potential. H.C. Wainwright analyst Patrick Trucchio reiterated ...
In other news this week: CHARM Therapeutics raises €68.2M, MRM Health secures €55M, HappyRobot bags €37.7M funding and more
Lately, there’s been a lot happening in the technology world. Startups and established companies are busy announcing new funding, forming ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.